Presentation is loading. Please wait.

Presentation is loading. Please wait.

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention 

Published byElfreda Greene Modified over 5 years ago

Similar presentations

Presentation on theme: "Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention "— Presentation transcript:

1 Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention  Jason G. Andrade, MD, Andrew D. Krahn, MD, Allan C. Skanes, MD, Daniel Purdham, PhD, Antonio Ciaccia, MSc, Sean Connors, MD, PhD  Canadian Journal of Cardiology  Volume 32, Issue 6, Pages (June 2016) DOI: /j.cjca Copyright © 2016 The Authors Terms and Conditions

2 Figure 1 Results of the physician survey regarding oral anticoagulant preferences and practices. (A) The physician stated preferred anticoagulant profile (on the basis of attribute profile alone, with no knowledge of the specific agent; note: attributes of dabigatran were not included). (B) The physician stated spontaneously volunteered preferred anticoagulant agent. (C) The relative proportion of agents prescribed among the past 10 patients. Canadian Journal of Cardiology  , DOI: ( /j.cjca ) Copyright © 2016 The Authors Terms and Conditions

3 Figure 2 Conjoint analysis. The relative importance of each attribute (ie, the measure of how much effect an attribute has relative to the other attributes), independently assessed by patients and physicians. Canadian Journal of Cardiology  , DOI: ( /j.cjca ) Copyright © 2016 The Authors Terms and Conditions

4 Figure 3 Perception regarding the degree of collaboration for oral anticoagulant initiation. Among patients who were presented with several treatment options by their physician the perception regarding the individual making the ultimate treatment decision differed among patients and physicians. Canadian Journal of Cardiology  , DOI: ( /j.cjca ) Copyright © 2016 The Authors Terms and Conditions

5 Figure 4 Therapy adherence. (A) Proportion of patients with missed doses of their anticoagulant in the past week, stratified according to agent and number of missed doses. (B) Proportion of patients who are currently using the wrong dosing frequency of their anticoagulant. (C) Proportion of patients who had considered stopping their anticoagulant therapy within the past year. OAC, oral anticoagulant. Canadian Journal of Cardiology  , DOI: ( /j.cjca ) Copyright © 2016 The Authors Terms and Conditions

Download ppt "Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention "

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,
Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.

Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.
The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.
Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.

Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Volume 370, Issue 9586, Pages (August 2007)

Volume 370, Issue 9586, Pages (August 2007)
To Anticoagulate or not to Anticoagulate

To Anticoagulate or not to Anticoagulate
Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 
Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients—Analysis of Pharmaceuticals and Medical Devices Agency Data 

Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants in Japanese Patients—Analysis of Pharmaceuticals and Medical Devices Agency Data 
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.
An approach to using risk scores for stroke and bleeding in clinical practice. An approach to using risk scores for stroke and bleeding in clinical practice.

An approach to using risk scores for stroke and bleeding in clinical practice. An approach to using risk scores for stroke and bleeding in clinical practice.
American Heart Journal

American Heart Journal
171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.

A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
Frontiers of anticoagulation therapy for atrial fibrillation

Frontiers of anticoagulation therapy for atrial fibrillation
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.
The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence  David D. Waters, MD, Sripal Bangalore, MD,

The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence  David D. Waters, MD, Sripal Bangalore, MD,
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Similar presentations

Ads by Google